WASHINGTON, D.C. (July 27, 2006) -- Advance media registration is now available online for the Biotechnology Industry Organization’s (BIO) Mid-America VentureForum 2006, scheduled for September 25-27 at the Intercontinental Hotel in Cleveland, OH.
The BIO Mid-America VentureForum is the Midwest’s largest annual event, bringing together biotechnology and medical device companies, venture capitalists, angel investors, and investment bankers from across the U.S. and Canada. Now in its fourth year, the conference is co-hosted by BIO and eight state biotechnology associations: Omeris, Colorado BioScience Association, the Illinois Biotechnology Industry Organization, Indiana Health Industry Forum, Iowa Biotechnology Association, LifeScience Alley, Missouri Biotechnology Association, and the Wisconsin Biotechnology Association.
The conference will feature presentations by companies selected by an advisory board consisting of representatives from the nation’s leading venture capital firms and workshops on timely issues such as state growth initiatives, investing in cutting-edge technology such as stem cell research and personalized medicine, and strategies for accelerating the regulatory review process.
Confirmed speakers include Dr. Andrew von Eschenbach, Acting Commissioner of the Food and Drug Administration, and Ohio Governor Bob Taft.
Registration is complimentary for credentialed news media. Advance registration is available at http://www.bio.org/news/pressreg/index.asp?multiEvent=17 through September 15, 2006. Onsite registration is available only to reporters and editors working full-time for print or broadcast news organizations with valid media credentials.
For additional information on the BIO Mid-America VentureForum, please visit http://bma.bio.org/opencms/bma/2006/index.jsp .
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.